Press coverage about Mannatech (NASDAQ:MTEX) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mannatech earned a news impact score of 0.16 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.9815258175123 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Mannatech traded down $0.65, reaching $19.95, on Monday, Marketbeat.com reports. 8,000 shares of the company’s stock were exchanged, compared to its average volume of 11,787. Mannatech has a twelve month low of $13.50 and a twelve month high of $22.40. The firm has a market capitalization of $56.02 million, a PE ratio of 13.73 and a beta of 0.79.
Mannatech (NASDAQ:MTEX) last announced its quarterly earnings data on Tuesday, May 8th. The company reported $0.30 earnings per share for the quarter. Mannatech had a positive return on equity of 10.15% and a negative net margin of 0.45%. The firm had revenue of $41.38 million for the quarter.
The company also recently announced a quarterly dividend, which was paid on Wednesday, May 30th. Shareholders of record on Wednesday, May 23rd were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 2.51%. The ex-dividend date was Tuesday, May 22nd.
Separately, ValuEngine raised Mannatech from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd.
Mannatech, Incorporated provides wellness solutions. The company develops, markets, and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It markets its products through network marketing channels in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific.
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.